SERPINE1 and ovarian cancer: Recent in vivo studies have noted that PAI-1 inhibitors suppress tumor growth, angiogenesis, and metastasis of some cancers (e.g., ovarian cancer, lung carcinoma, urothelial carcinoma, and fibrosarcoma) [33–36].